- 
				
Quantitative susceptibility mapping and blood neurofilament light chain differentiate between parkinsonian disorders
 - 
				
Quantitative systems pharmacology modelling of Parkinson’s disease to compare anti-α-synuclein therapeutics
 - 
				
Racial and ethnic differences in patients with Parkinson’s Disease across Parkinson’s Disease Centers of Excellence
 - 
				
Randomised Controlled Trial Comparing Efficacy of Zonisamide 25 mg given in addition to standard treatment with standard treatment alone in Tremor dominant Parkinson’s Disease- A Pilot study.
 - 
				
Randomized, Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of ABBV-0805, an Anti-Alpha-Synuclein Monoclonal Antibody in Healthy Subjects
 - 
				
Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson’s disease
 - 
				
Rapid blinking as an early clinical marker of Parkinson’s disease
 - 
				
Rapid Onset Stiff Person Syndrome
 - 
				
Rapidly progressive dementia after MRI-guided Focused Ultrasound (MR-FUS)
 - 
				
Rare Neurodegenerative Phenotypes in Patients Carrying Homozygous GBA1 Mutations
 
- « Previous Page
 - 1
 - …
 - 97
 - 98
 - 99
 - 100
 - 101
 - …
 - 132
 - Next Page »
 
